Otcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F04%3A00000989" target="_blank" >RIV/00023001:_____/04:00000989 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Otcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
Original language description
BACKGROUND: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial was designed to test the hypothesis that for the same blood-pressure control, valsartan would reduce cardiac morbidity and mortality more than amlodipine in hypertensive patients at high cardiovascular risk.
Czech name
Výsledné stavy u hypertoniků s vysokým kardiovaskulárním rizikem léčených režimy s valsartanem nebo amlodipinem: randomizovaná studie VALUE
Czech description
hypertonici, kardiovaskulárním riziko, léčba valsartanem nebo amlodipinem, randomizovaná studie VALUE
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2004
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Lancet
ISSN
0140-6736
e-ISSN
—
Volume of the periodical
363
Issue of the periodical within the volume
9426
Country of publishing house
GB - UNITED KINGDOM
Number of pages
10
Pages from-to
2022-2031
UT code for WoS article
—
EID of the result in the Scopus database
—